20 February 2026
Zenniz Completes $6 Million Raise, Establishing USA HQ
Zenniz, the world's leading provider of smart tennis court solutions, successfully completed a new $6M USD funding round backed by multiple VC funds.
The investors...
All
11 February 2026
Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis
Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces positive...
10 February 2026
Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies
Kainova Therapeutics (“the Company”), a key player for breakthrough treatments for patients in immuno-oncology and inflammation, today announced the successful first close...
29 January 2026
Enterome appoints leading hematologist and IFLI Executive Partner Mehrdad Mobasher, M.D., M.P.H., to its Board of Directors
Enterome SA, a clinical-stage company pioneering OncoMimics™, a new class of off-the-shelf, multi-targeted in vivo immune therapies that induce a fast and potent expansion of...
21 January 2026
ErVimmune raises €17 million in Series A first closing to enter clinical development with lead cancer vaccine candidate
ErVimmune, a biotechnology company developing next-generation therapeutic vaccines targeting new families of ‘unconventional’ tumor antigens derived from human endogenous...
20 January 2026
MaaT Pharma Announces First Patient Randomized in IMMUNOLIFE Phase 2 Study Sponsored by Gustave Roussy, To Explore the Role of the Gut Microbiome To Overcome ICI Resistance in Advanced NSCLC Patients with Antibiotic-Induced Dysbiosis
MaaT Pharma Announces First Patient Randomized in IMMUNOLIFE Phase 2 Study Sponsored by Gustave Roussy, To Explore the Role of the Gut Microbiome To Overcome ICI Resistance in...
12 January 2026
The Sanctuary Group raises €5 million to roll out its sports studios across France
Specializing in fitness studios, French startup The Sanctuary Group has announced that it has raised €4.7 million in funding. This will enable it to accelerate the rollout of...
17 December 2025
SkillCorner Secures $60M Growth Investment to Accelerate Global Sports Data Innovation
SkillCorner is pleased to announce a $60 million growth investment from Silversmith Capital Partners, marking an important step forward in our mission to deliver world-leading...
10 December 2025
Vertero Establishes Scientific Advisory Board to Advance Innovation in Neurodegenerative Diseases
Vertero Therapeutics, a clinical-stage biotechnology company breaking barriers in neurodegenerative disease treatment, today announced the appointment of five globally...
8 December 2025
MaaT Pharma Presents Pivotal ARES Phase 3 Results for MaaT013 (Xervyteg®) in Acute GvHD at ASH 2025 Annual Congress and Announces 54% 1-Year Overall Survival
MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated...